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We report the ﬁrst known case of a retroperitoneal leiomyosarcoma that presented with an endoscopically deﬁned source of
gastrointestinal bleeding in the colon. A 68-year-old male with a history of diverticulosis, hypertension, and hypercholesterolemia
who complained of a 3-month history of abdominal pain, nausea, and intermittent hematochezia presented for evaluation of large
volume hematochezia and lightheadedness. Colonoscopy revealed left-sided diverticulosis and rectal varices without stigmata of
recent bleed. CT scan showed a 26 × 20 × 13cm heterogeneous retroperitoneal mass and multiple hypodense hepatic lesions.
Liver biopsy revealed leiomyosarcoma. In summary, although surgery is the mainstay of treatment, resectability has not improved
signiﬁcantly. Early recognition and aggressive surgery are keys to long-term survival.
1.Introduction
Retroperitoneal soft-tissue sarcomas rare. They are locally
invasive, large tumors that usually present with abdominal
discomfort and palpable mass. They rarely present with
lower gastrointestinal bleeding. We report the ﬁrst known
case of a retroperitoneal leiomyosarcoma that presented with
an endoscopically deﬁned source of gastrointestinal bleeding
in the colon.
2. Case Presentation
We present a case of a 68-year-old male with a history of
diverticulosis, hypertension, and hypercholesterolemia who
complained of a 3-month history of abdominal pain, nausea,
and intermittent hematochezia. He presented to the emer-
gencyroomforevaluationoflargevolumehematocheziaand
lightheadedness.
Physical examination revealed a systolic blood pressure
of 80mmHg. Abdominal exam showed mild distension and
diﬀuse tenderness. Nasogastric lavage was clear. Rectal exam
was notable for bright red blood, but no mass or hemor-
rhoids. Laboratory evaluation showed blood urea nitrogen
(BUN) = 35mg/dL, creatinine = 1.9mg/dL, international
normalized ratio (INR) = 1.4, hemoglobin = 4.8g/dL, and
platelet count = 498,000k/mcl.
Upper endoscopy revealed a hiatal hernia and extrinsic
compression of the second part of the duodenum, but there
were no signs of active or recent bleeding. Colonoscopy
revealed left-sided diverticulosis and rectal varices without
stigmata of recent bleed. Additionally, a large cavity was
found in the proximal ascending colon with a necrotic mass
and surrounding varices (Figure 1). No active bleeding was
observed. CT scan showed a 26 × 20 × 13cm heterogeneous
retroperitoneal mass, multiple hypodense hepatic lesions,
grade2right-sidedhydronephrosis,andmildlydilatedproxi-
malsmallbowelwithnoevidenceofsmallbowel obstruction
(Figure 2). Liver biopsy revealed leiomyosarcoma.
The patient underwent exploratory laparotomy for pal-
liative right hemicolectomy and was found to have a large
tumor extending from the right retroperitoneum lateral to
therightcolonandanteriortotherightkidney.Themasswas
invading the colonic mesentery and encased the proximal
one-third of the superior mesenteric artery. Therefore, he
was deemed inoperable and was discharged home with
hospice care.2 Case Reports in Gastrointestinal Medicine
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Figure 1: (a) Ascending colon with ileocecal valve in the distance
and cavity at the 12 o’clock position. (b) View into cavity. (c) Mass
and varices seen distal to the cavity.
3. Discussion
Soft-tissue sarcomas are rare accounting for approximately
1% of adult malignancies. Fifty percent of these occur
in the extremities followed by retroperitoneal/visceral and
trunk involvement [1]. Retroperitoneal soft-tissue sarcomas
account for 13% of all adult soft-tissue sarcomas with
malignant ﬁbrous histiocytomas and liposarcomas being
the most common. They are locally invasive, large tumors
that remain occult for long periods of time due to the
abdominal cavity’s ability to accommodate these slowly
expanding masses with a paucity of symptoms [2]. Most
cases present with abdominal discomfort (60%–70%) and
Figure 2: Large retroperitoneal mass near right colon and SMA.
palpable mass (70%–80%) but rarely do they present with
lower gastrointestinal bleeding [3].
T h e r eh a v eb e e n3 6c a s e sr e p o r t e do fd u o d e n o c a v a l
ﬁstula and one case of gastric invasion of retroperitoneal
sarcomascausinggastrointestinalbleeding[4,5],allofwhich
have been after surgical resection and/or radiation therapy.
One case has been reported of a lower gastrointestinal
bleed from direct invasion of a retroperitoneal liposarcoma
invading the terminal ileum; however, the site could not
be found endoscopically [6]. This is the ﬁrst known case
of a retroperitoneal leiomyosarcoma that presented with an
endoscopically deﬁned source of gastrointestinal bleeding in
the colon.
The overall 5-year survival rate of retroperitoneal sar-
comas 36%–58% and is dependent on tumor histology
and extent of tumor invasion [7]. Surgery is the mainstay
of treatment, but despite improved imaging techniques
and preoperative and intraoperative patient management,
the incidence of successful resection has not improved
signiﬁcantly in the past 20 years. Even with aggressive
surgical techniques, only one half of tumors can be resected
completely, and of those, up to 90% result in local recurrence
and result in death [8]. In a case series of 73 patients treated
from 1984 to 2003, 69.8% were resected completely with
a local recurrence rate of 37.2% and a 5-year survival of
58%. The 5-year survival of the remaining patients was 0%
[9].
In contrast to the promising results seen with extremity
soft-tissue sarcoma and childhood sarcomas, the addition
of adjuvant radiotherapy or chemotherapy has not altered
prognosis. In a review of 312 patients with abdominal
and truncal sarcomas treated from 1977 to 2004, the
ability to resect the lesion, negative resection margins, and
tumor histology were the only good prognostic factors
[10]. Liposarcomas and ﬁbrosarcomas had better outcomes
than leiomyosarcomas or malignant ﬁbrous histiocytomas.
Chemoradiotherapy did not improve outcomes. Adjuvant
and neoadjuvant chemoradiotherapy are being used but
further investigation is necessary [11].
Early recognition and aggressive surgery are the keys to
long-termsurvivalofpatientswithretroperitonealsarcomas,
but the mainstay of treating advanced disease is yet toCase Reports in Gastrointestinal Medicine 3
be determined and needs further research as the overall
prognosis of advanced disease is relatively poor.
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